Skip to content

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.

A2 Milk share price: where next as top broker raises target price?

As the ASX 200 struggles, a2 Milk has helped bolster Australia’s consumer staples index today.

A2 Milk share price in focus Source: Bloomberg

ASX 200: a red affair

A2 Milk (ASX: A2M) has today helped boost the ASX’s consumer staples sector – with the XSJ index rising 1.04% by the afternoon session – reaching the 13,245 point mark. The blue-chip benchmark fared less well overall – with the ASX 200 falling 0.19% – to 7,066 points.

All up, a2 Milk has today seen its share price rise 1.02% – to $14.81 per share – likely after news circulated the market that one of A2’s more bearish critics, had moderated their view on the milk stock, somewhat.

Specifically, as The Australian today wrote:

‘The stock was upgraded by Citi after analysis of distribution channels, with Australian retail stores and daigou channels showing many of its products were out of stock. Analyst Sam Teeger notes that daigou feedback indicates that a2 remains the most popular brand even after recent price increases.’

Here, Sam Teeger has raised Citi’s price target on a2 Milk (ASX: A2M) from $12.30 to $14.85 per share – and upgraded the rating on the stock from sell to neutral.

Practise trading Australian stocks with an IG demo account now

A2 Milk share price: the changing narrative

Previous research from Citi, compiled post A2-AGM, noted that while the company’s momentum remained strong, margin issues over the medium-term remained and that increased investment spending was still likely required. That research also noted that A2 was expected to face increased competition – though the full implications of such competition may take some time to fully play-out.

'While further marketing delays could see short-term EBITDA margins beating expectations, over the medium-term we expect margins to decline from i) investment required to drive sales in an increasingly-competitive China IMF market, and ii) the shift to direct channels,’ noted Citi in November.

Ultimately, though A2’s share price outperformed the market today – it has been a decisively volatile stock in the last six months – both operationally and from a share price perspective.

First, the company undershot analyst earnings (EBITDA) estimates, while also providing a weaker than expected margin outlook during its FY19 earnings results. The stock was battered by investors in response: dropping 14% off the back of those results.

The stock continued to drop after that: bottoming-out at $11.31 per share in November.

In saying that, when A2 noted that it expected FY20 (EIBTDA) margins to come in better than previously expected, during the company’s November AGM – its share price steadily ticked up.

If fundamentals were worrying investors for a time – a drastic shakeup of the C-suite seemed less concerning through all this commotion. Specifically, A2 has lost its CMO, CEO and most recently CTO, over the last six months.

A2M is expected to report its first-half results on February 27.

This information has been prepared by IG, a trading name of IG Markets Ltd and IG Markets South Africa Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.

Seize a share opportunity today

Go long or short on thousands of international stocks.

  • Increase your market exposure with leverage
  • Get spreads from just 0.1% on major global shares
  • Trade CFDs straight into order books with direct market access

Live prices on most popular markets

  • Forex
  • Shares
  • Indices

Prices above are subject to our website terms and agreements. Prices are indicative only

Plan your trading week

Get the week’s market-moving news sent directly to your inbox every Monday. The Week Ahead gives you a full calendar of upcoming economic events, as well as commentary from our expert analysts on the key markets to watch.

You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.